Lung Cancer Trials Ask AI to find trials
CompletedNot applicableNCT00905086
Official study title

Psychosocial Adjustment After Radiation Therapy in Patients With Cancer

Study summary

RATIONALE: Gathering information about psychological and social adjustment after radiation therapy in patients with cancer may help doctors plan the best treatment. PURPOSE: This clinical trial is studying psychosocial adjustment after radiation therapy in patients with breast cancer, colorectal cancer, lung cancer, or prostate cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalNot specified

This describes the study’s primary purpose.

What is being studiedquestionnaire administration and cognitive assessment

Plus 2 other study approaches.

Who it may be forBreast Cancer · Cognitive/Functional Effects

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated Sep 30, 2015 · Source: ClinicalTrials.gov

Is enrollment open?Completed

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Observational

Where is it offered?1 U.S. location

Locations may change over time.

Who runs it?Case Comprehensive Cancer Center

Study sponsor

01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Case Comprehensive Cancer Center
Interventions being studied
Other: questionnaire administration; Procedure: cognitive assessment; Procedure: psychosocial assessment and care; Procedure: quality-of-life assessment
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Radiation therapy→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • DISEASE CHARACTERISTICS:
  • Diagnosis of breast, colorectal, lung, or prostate cancer
  • Stage I, II, or III disease
  • Nonmetastatic disease
  • Undergoing first course of curative radiotherapy, as indicated in the medical record
  • Receiving treatment as an outpatient
  • Hormone receptor status not specified PATIENT CHARACTERISTICS:
  • Menopausal status not specified
  • Able to receive treatment as an outpatient
  • Lives in northeastern Ohio
  • Cognitively intact, as evidenced by orientation to person, place, and time
  • Has a telephone
  • No hearing impairment (must be able to hear instructions)
  • No malignancy expected to require surgery or chemotherapy ≤ 2 months after treatment PRIOR CONCURRENT THERAPY:
  • See Disease Characteristics
  • No prior radiotherapy for another type of cancer
  • No concurrent or planned chemotherapy or surgery for at least 2 months after radiotherapy
  • No concurrent treatment for recurrent cancer

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer CenterCleveland, Ohio

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Sep 30, 2015. Always confirm current availability with the study team.

View original record ↗